The Government Is Making Telemedicine Hard And Inconvenient Again

Scott (a telepsychiatrist) on DEA-407, which restricts telemedicine prescribing of controlled substances (Adderall, benzodiazepines) once COVID-era flexibility lapsed. The 'loopholes' (one in-person visit, or another doctor's referral letter) don't filter evil overprescribers -- pill mills will trivially clear them -- but burden legitimate doctors and vulnerable patients (rural, agoraphobic, mobile, low-income), some of whom can't safely stop their meds. The core point: the in-person-visit hurdle is uncorrelated with the harm (overprescribing) it's meant to catch, so it's pure deadweight that pushes telemedicine back toward the very inconvenience it was invented to remove, and will ambush crisis patients. Written quickly as an evolving-situation explainer, with a wall of corroborating critical commentary and a (futile) DEA-comment link.

Quality 66 · Strong. Strong/Solid edge. A sharp, first-person regulation critique whose best move (the filter is uncorrelated with the harm; the meth-dealer clears the hurdle too) is genuinely clarifying -- but it's a quick, reactive, narrow topical piece on one rule, with no constructive proposal. Mid-Solid-to-Strong.

Claude’s paradigm shift 40 · Moderate. Moderate. Mostly a topical critique; the mild insight is the uncorrelated-filter point.

Real-world impact 2 · Minor. Minor. Targets a real, consequential DEA rule, but the post itself is advocacy/commentary. Within-niche.